JP2021504468A5 - - Google Patents
Info
- Publication number
- JP2021504468A5 JP2021504468A5 JP2020545883A JP2020545883A JP2021504468A5 JP 2021504468 A5 JP2021504468 A5 JP 2021504468A5 JP 2020545883 A JP2020545883 A JP 2020545883A JP 2020545883 A JP2020545883 A JP 2020545883A JP 2021504468 A5 JP2021504468 A5 JP 2021504468A5
- Authority
- JP
- Japan
- Prior art keywords
- propylene glycol
- glycerol
- pharmaceutical preparation
- hydroxyandrostan
- preparation according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762590757P | 2017-11-27 | 2017-11-27 | |
| US62/590,757 | 2017-11-27 | ||
| PCT/EP2018/082727 WO2019102040A1 (en) | 2017-11-27 | 2018-11-27 | PHARMACEUTICAL FORMULATION OF 3α-ETHYNYL-3β-HYDROXYANDROSTAN-17-ONE OXIME |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021504468A JP2021504468A (ja) | 2021-02-15 |
| JP2021504468A5 true JP2021504468A5 (https=) | 2023-03-30 |
| JP7314459B2 JP7314459B2 (ja) | 2023-07-26 |
Family
ID=64556898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020545883A Active JP7314459B2 (ja) | 2017-11-27 | 2018-11-27 | ３α－エチニル－３β－ヒドロキシアンドロスタン－１７－オンオキシムの医薬製剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10603326B2 (https=) |
| EP (1) | EP3716954A1 (https=) |
| JP (1) | JP7314459B2 (https=) |
| KR (1) | KR102771577B1 (https=) |
| CN (1) | CN111432805B (https=) |
| AU (1) | AU2018374029B2 (https=) |
| BR (1) | BR112020010519A2 (https=) |
| CA (1) | CA3083555A1 (https=) |
| IL (1) | IL274893B2 (https=) |
| MX (1) | MX391097B (https=) |
| UA (1) | UA128186C2 (https=) |
| WO (1) | WO2019102040A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3716954A1 (en) | 2017-11-27 | 2020-10-07 | Umecrine Cognition AB | Pharmaceutical formulation of 3 -ethynyl-3 -hydroxyandrostan-17-one oxime |
| EP4079307A1 (en) | 2021-04-20 | 2022-10-26 | Umecrine Cognition AB | New medical use |
| EP4389129A1 (en) | 2022-12-22 | 2024-06-26 | Umecrine Cognition AB | 3a-ethynyl-3beta hydroxyandrostan 17-one oxime for treating parkinson's disease and l-dopa-induced dyskinesia |
| WO2025252725A1 (en) | 2024-06-04 | 2025-12-11 | Umecrine Cognition Ab | Novel pharmaceutical formulation of golexanolone |
| WO2025252724A1 (en) | 2024-06-04 | 2025-12-11 | Umecrine Cognition Ab | Novel pharmaceutical formulation of golexanolone |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9405304D0 (en) | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
| GB9608719D0 (en) | 1996-04-26 | 1996-07-03 | Scherer Ltd R P | Pharmaceutical compositions |
| SE511313C2 (sv) | 1997-01-13 | 1999-09-06 | Gs Dev Ab | Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol |
| GB9907715D0 (en) | 1999-04-01 | 1999-05-26 | Scherer Corp R P | Pharmaceutical compositions |
| KR20010100194A (ko) * | 2000-03-13 | 2001-11-14 | 박호군 | 여러 가지 물질의 가용화용 조성물과 제형 및 그들의제조방법 |
| US20040191207A1 (en) | 2003-03-31 | 2004-09-30 | Lipari John M. | Alpha-hydroxy acid ester drug delivery compositions and methods of use |
| US20100209496A1 (en) | 2006-09-06 | 2010-08-19 | Eleni Dokou | Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide |
| DK2792681T3 (en) | 2006-11-21 | 2017-01-23 | Umecrine Ab | Use of Pregnancy and Androstan Steroids in the Preparation of a Pharmaceutical Composition for the Treatment of CNS Disorders. |
| RU2012133627A (ru) | 2010-01-14 | 2014-04-20 | Умекрине Муд Аб | Фармацевтическая композиция, содержащая 3-бета-гидрокси-5-альфа-прегнан-20-он, с улучшенными свойствами хранения и растворимости |
| US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US8951996B2 (en) | 2011-07-28 | 2015-02-10 | Lipocine Inc. | 17-hydroxyprogesterone ester-containing oral compositions and related methods |
| US9801819B2 (en) | 2012-06-28 | 2017-10-31 | Johnson & Johnson Consumer Inc. | Racecadotril compositions |
| HK1223300A1 (zh) * | 2013-06-03 | 2017-07-28 | Tolmar, Inc. | 皮质类固醇组合物 |
| RU2684616C2 (ru) * | 2014-01-29 | 2019-04-10 | Умекрин Когнишн Аб | Стероидное соединение для применения в лечении печеночной энцефалопатии |
| WO2015193224A1 (en) | 2014-06-17 | 2015-12-23 | Merck Sharp & Dohme B.V. | Stable formulations of testosterone undecanoate |
| US9498485B2 (en) * | 2014-08-28 | 2016-11-22 | Lipocine Inc. | Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters |
| KR101679992B1 (ko) | 2015-12-31 | 2016-11-28 | 주식회사 유유제약 | 프로필렌글리콜 모노라우레이트를 포함하는 두타스테리드의 약학적 조성물 및 이의 제조 방법 |
| KR101716878B1 (ko) | 2016-05-12 | 2017-03-15 | 주식회사 유유제약 | 글리세롤 지방산에스테르유도체 또는 프로필렌글리콜 지방산에스테르유도체를 함유한 두타스테리드와 타다라필의 복합 캡슐제제 조성물 및 이의 제조방법 |
| US10278977B2 (en) | 2016-06-06 | 2019-05-07 | Umecrine Cognition Ab | Methods for treating hypersomnolence |
| EP3716954A1 (en) | 2017-11-27 | 2020-10-07 | Umecrine Cognition AB | Pharmaceutical formulation of 3 -ethynyl-3 -hydroxyandrostan-17-one oxime |
-
2018
- 2018-11-27 EP EP18811225.4A patent/EP3716954A1/en active Pending
- 2018-11-27 KR KR1020207018543A patent/KR102771577B1/ko active Active
- 2018-11-27 UA UAA202003834A patent/UA128186C2/uk unknown
- 2018-11-27 CN CN201880076423.8A patent/CN111432805B/zh active Active
- 2018-11-27 BR BR112020010519-8A patent/BR112020010519A2/pt unknown
- 2018-11-27 MX MX2020005442A patent/MX391097B/es unknown
- 2018-11-27 WO PCT/EP2018/082727 patent/WO2019102040A1/en not_active Ceased
- 2018-11-27 AU AU2018374029A patent/AU2018374029B2/en active Active
- 2018-11-27 CA CA3083555A patent/CA3083555A1/en active Pending
- 2018-11-27 JP JP2020545883A patent/JP7314459B2/ja active Active
- 2018-11-27 IL IL274893A patent/IL274893B2/en unknown
-
2019
- 2019-06-24 US US16/450,620 patent/US10603326B2/en active Active
-
2020
- 2020-02-21 US US16/797,426 patent/US11123351B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021504468A5 (https=) | ||
| JP4636692B2 (ja) | 長鎖トリグリセリドと親油性界面活性剤とを含有する経口医薬組成物 | |
| JP2015520236A5 (https=) | ||
| JPWO2022234850A5 (https=) | ||
| JP2023015334A5 (https=) | ||
| JP7314459B2 (ja) | ３α－エチニル－３β－ヒドロキシアンドロスタン－１７－オンオキシムの医薬製剤 | |
| CN112691078A (zh) | 含有紫杉烷的用于口服给药的药物组合物 | |
| KR20140016926A (ko) | 활성제로서 페닐아미노피리미딘 유도체를 포함하는 제제 | |
| US10806742B2 (en) | Liquid phospholipid-containing compositions for the preparation of pharmaceuticals | |
| US10960016B2 (en) | Capsules containing high doses of krill phospholipids | |
| NZ764901B2 (en) | PHARMACEUTICAL FORMULATION OF 3a-ETHYNYL-3ß-HYDROXYANDROSTAN-17-ONE OXIME | |
| RU2779262C2 (ru) | ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ 3α-ЭТИНИЛ-3β-ГИДРОКСИАНДРОСТАН-17-ОНА ОКСИМА | |
| US11690835B2 (en) | Formulation | |
| US20190247308A1 (en) | Stable liquid formulations | |
| HK40041450A (en) | Pharmaceutical composition for oral administration comprising taxane | |
| HK40041450B (en) | Pharmaceutical composition for oral administration comprising taxane | |
| HK1240118A1 (en) | Pharmaceutical composition for oral administration comprising taxane |